Utama › Karsinoma Urotelial (Sel Transisi)
Kajian klinikal Karsinoma Urotelial (Sel Transisi) sedang mengambil peserta di AS
72 kajian untuk Karsinoma Urotelial (Sel Transisi) sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Nashville, TN23 kajian
- New York City, NY22 kajian
- Dallas, TX18 kajian
- Edison, NJ18 kajian
- Houston, TX18 kajian
- Los Angeles, CA17 kajian
- Queens, NY15 kajian
- Chicago, IL14 kajian
- Arlington, VA12 kajian
- San Antonio, TX11 kajian
- Boston, MA11 kajian
- Austin, TX10 kajian
- Orange, CA10 kajian
- Philadelphia, PA9 kajian
- Washington, DC9 kajian
- Columbus, OH9 kajian
- Baldwin Park, CA9 kajian
- Atlanta, GA8 kajian
- Cleveland, OH8 kajian
- Jacksonville, FL8 kajian
- Durham, NC8 kajian
- Seattle, WA8 kajian
- Irvine, CA8 kajian
- Orlando, FL7 kajian
- Omaha, NE7 kajian
- Portland, OR7 kajian
- San Francisco, CA7 kajian
- St. Louis, MO7 kajian
- New Rochelle, NY7 kajian
- Staten Island, NY7 kajian
- Greenburgh, NY7 kajian
- Milwaukee, WI6 kajian
- Denver, CO6 kajian
- Phoenix, AZ6 kajian
- New Haven, CT6 kajian
- Detroit, MI6 kajian
- Gainesville, FL6 kajian
- Oklahoma City, OK6 kajian
- Charlotte, NC6 kajian
- Ann Arbor, MI6 kajian
Mengikut negeri
- Alabama4 kajian
- Arizona10 kajian
- Arkansas5 kajian
- California33 kajian
- Colorado10 kajian
- Connecticut7 kajian
- Florida22 kajian
- Georgia11 kajian
- Idaho4 kajian
- Illinois21 kajian
- Indiana7 kajian
- Iowa7 kajian
- Kentucky4 kajian
- Louisiana4 kajian
- Maryland8 kajian
- Massachusetts15 kajian
- Michigan15 kajian
- Minnesota7 kajian
- Missouri10 kajian
- Montana3 kajian
- Nebraska7 kajian
- Nevada3 kajian
- New Jersey21 kajian
- New York29 kajian
- North Carolina15 kajian
- Ohio17 kajian
- Oklahoma8 kajian
- Oregon8 kajian
- Pennsylvania15 kajian
- South Carolina8 kajian
- South Dakota3 kajian
- Tennessee25 kajian
- Texas38 kajian
- Utah6 kajian
- Virginia21 kajian
- Washington12 kajian
- Wilayah Columbia7 kajian
- Wisconsin9 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06524544A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07090499Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Mengambil peserta
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06262516The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05874921DBC-664 in Adult Patients With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07705035A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05562830Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06439836Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05239624Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07043972A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07532902GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04977453A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07815665A Study of GEN1106 in Participants With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07416123A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06040762Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.